# PVCT (Provectus Biopharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Provectus Biopharmaceuticals, Inc. reported $336K in revenue and a net loss of $4.70M for the fiscal year ended December 31, 2025 (down 45.5% year over year), with a -1344.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/PVCT
- Markdown: https://convexityos.com/fundamentals/PVCT.md
- SEC CIK: 0000315545
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000315545&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $336K | -45.5% YoY |
| Operating Income | FY 2025 | -$4.52M | -1344.3% margin |
| Net Income | FY 2025 | -$4.70M | -1399.7% net margin |
| Diluted EPS | FY 2025 | -$0.01 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $181K | Total debt: $92K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $336K | $617K | $558K | $989K | -- | -- | -- | -- | -- | -- |
| Research & Development | $1.90M | $2.05M | $1.75M | $2.39M | $2.61M | $2.81M | $4.00M | $4.75M | $8.20M | $8.21M |
| Total Operating Expenses | $5.63M | $5.15M | $3.46M | $4.42M | $4.67M | $4.96M | $6.30M | $8.05M | -- | -- |
| **Operating Income** | -$5.29M | -$4.53M | -$2.90M | -$3.43M | -$4.67M | -$4.96M | -$6.30M | -$8.05M | -$13.32M | -$24.51M |
| **EBITDA** | -$5.29M | -$4.53M | -$2.89M | -$3.42M | -$4.66M | -$4.72M | -$5.61M | -$7.37M | -$12.63M | -$23.83M |
| Interest Income | -- | -- | -- | -- | $4 | $3.4K | $23K | $20K | $31K | $2.1K |
| Interest Expense | $5.3K | $14K | $5.7K | $3.4K | $962K | $1.75M | $1.46M | $970K | -- | -- |
| Income Before Tax | -$5.51M | -$4.77M | -$3.10M | -$3.55M | -$5.54M | -$6.68M | -$6.92M | -$8.15M | -$13.52M | -- |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Income** | -$5.43M | -$4.73M | -$3.10M | -$3.55M | -$5.54M | -$6.68M | -$6.92M | -$8.15M | -$13.52M | -$24.43M |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.02 | -$0.02 | -$0.04 | -$0.12 |
| **Diluted EPS** | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.02 | -$0.02 | -$0.04 | -$0.12 |
| Basic Shares Outstanding | 420.3M | 419.8M | 419.5M | 419.5M | 408.2M | 393.3M | 386.6M | 382.3M | 369.2M | 233.8M |
| Diluted Shares Outstanding | 420.3M | 419.8M | 419.5M | 419.5M | 408.2M | 393.3M | 386.6M | 382.3M | 369.2M | 233.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $57K | $279K | $14K |
| Research & Development | $240K | $131K | $333K | $268K | $346K | $881K | $403K | $608K |
| Total Operating Expenses | $1.21M | $939K | $1.25M | $1.12M | $1.28M | $1.86M | $1.38M | $2.35M |
| **Operating Income** | -$1.21M | -$939K | -$1.25M | -$1.12M | -$1.28M | -$1.80M | -$1.10M | -$2.33M |
| **EBITDA** | -$1.21M | -$938K | -$1.25M | -$1.12M | -$1.28M | -$1.80M | -$1.10M | -$2.33M |
| Interest Expense | $62K | $50K | $53K | -- | $48K | $51K | $64K | -- |
| **Net Income** | -$1.27M | -$983K | -$1.29M | -$1.17M | -$1.31M | -$1.81M | -$1.14M | -$2.37M |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 420.3M | 420.3M | 420.3M | -- | 420.3M | 420.3M | 420.3M | -- |
| Diluted Shares Outstanding | 420.3M | 420.3M | 420.3M | -- | 420.3M | 420.3M | 420.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $251K | $307K | $77K | $22K | $683K | $97K | $591K | $51K | $106K | $1.17M |
| **Cash & Short-Term Investments** | $251K | $307K | $77K | $22K | $683K | $97K | $591K | $51K | $106K | $1.17M |
| Accounts Receivable, Net | -- | -- | $476 | $394 | $5.1K | $3.9K | $55K | $595K | -- | -- |
| Other Current Assets | $71K | $236K | -- | -- | -- | -- | -- | -- | -- | $361K |
| **Total Current Assets** | $568K | $977K | $1.36M | $1.90M | $3.44M | $424K | $996K | $1.02M | $958K | $1.83M |
| Property, Plant & Equipment, Net | $3.0K | $4.9K | $12K | $21K | $32K | $45K | $58K | $72K | $87K | $72K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $228K | $899K | $1.57M | $2.24M |
| **Total Non-Current Assets** | $130K | $29K | $84K | $138K | $71K | $166K | $481K | $972K | $2.48M | $3.78M |
| **Total Assets** | $698K | $1.01M | $1.45M | $2.04M | $3.51M | $589K | $1.48M | $1.99M | $3.44M | $5.61M |
| Accounts Payable | $716K | $1.11M | $1.68M | $2.09M | $1.29M | $957K | $1.13M | $3.31M | $3.27M | $1.92M |
| Deferred Revenue (Current) | -- | $336K | $953K | $1.51M | $2.50M | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $6.90M | $6.98M | $9.02M | $8.19M | $7.70M | $30.71M | $3.02M | $4.10M | $3.60M | $2.14M |
| **Total Non-Current Liabilities** | $103K | $0 | $25K | $73K | $0 | $84K | $22.53M | $15.30M | $9.86M | $0 |
| **Total Liabilities** | $7.00M | $6.98M | $9.04M | $8.27M | $7.70M | $30.80M | $25.55M | $19.41M | $13.46M | $2.14M |
| **Total Debt (incl. Leases)** | $127K | $25K | $73K | $118K | $46K | $129K | $207K | -- | -- | -- |
| Common Stock | $420K | $420K | $420K | $419K | $419K | $399K | $390K | $385K | $371K | $365K |
| Retained Earnings | -$262.9M | -$257.4M | -$252.7M | -$249.6M | -$246.0M | -$240.5M | -$233.8M | -$226.9M | -$218.7M | -$205.2M |
| Accumulated Other Comp. Income | -$60K | -$61K | -$60K | -$36K | -$34K | -$34K | -$24K | -- | -- | -- |
| **Total Stockholders' Equity** | -$6.30M | -$5.96M | -$7.59M | -$6.23M | -$4.19M | -$30.21M | -$24.07M | -$17.42M | -$10.02M | $3.47M |
| Total Equity | -$6.30M | -$5.97M | -$7.59M | -$6.23M | -$4.19M | -$30.21M | -$24.07M | -$17.42M | -$10.02M | $3.47M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $181K | $1.16M | $224K | $251K | $72K | $386K | $390K | $307K |
| **Cash & Short-Term Investments** | $181K | $1.16M | $224K | $251K | $72K | $386K | $390K | $307K |
| Other Current Assets | -- | -- | -- | $71K | $91K | $2.8K | -- | $236K |
| **Total Current Assets** | $375K | $1.37M | $460K | $568K | $278K | $568K | $649K | $977K |
| Property, Plant & Equipment, Net | $1.6K | $2.1K | $2.5K | $3.0K | $3.5K | $3.9K | $4.4K | $4.9K |
| **Total Non-Current Assets** | $92K | $105K | $117K | $130K | $142K | $154K | $17K | $29K |
| **Total Assets** | $467K | $1.47M | $578K | $698K | $420K | $722K | $666K | $1.01M |
| Accounts Payable | $604K | $932K | $815K | $716K | $1.18M | $1.31M | $744K | $1.11M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $57K | $336K |
| **Total Current Liabilities** | $7.11M | $7.71M | $7.24M | $6.90M | $6.47M | $6.49M | $5.74M | $6.98M |
| **Total Non-Current Liabilities** | $41K | $54K | $67K | $103K | $115K | $104K | $0 | $0 |
| **Total Liabilities** | $7.15M | $7.76M | $7.31M | $7.00M | $6.59M | $6.60M | $5.74M | $6.98M |
| **Total Debt (incl. Leases)** | $92K | $104K | $116K | $127K | $139K | $150K | $13K | $25K |
| Common Stock | $420K | $420K | $420K | $420K | $420K | $420K | $420K | $420K |
| Retained Earnings | -$266.4M | -$265.1M | -$264.1M | -$262.9M | -$261.7M | -$260.4M | -$258.6M | -$257.4M |
| Accumulated Other Comp. Income | -$60K | -$60K | -$60K | -$60K | -$60K | -$60K | -$61K | -$61K |
| **Total Stockholders' Equity** | -$6.66M | -$6.28M | -$6.72M | -$6.30M | -$6.15M | -$5.87M | -$5.10M | -$5.96M |
| Total Equity | -$6.68M | -$6.29M | -$6.73M | -$6.30M | -$6.17M | -$5.87M | -$5.07M | -$5.97M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.51M | -$4.76M | -$3.10M | -$3.55M | -$5.54M | -$6.68M | -$6.92M | -$8.15M | -$13.52M | -$24.43M |
| Depreciation & Amortization | $1.9K | $7.2K | $8.9K | $11K | $13K | $242K | $685K | $685K | $687K | $684K |
| Stock-Based Compensation | $1.24M | $1.28M | $2.9K | $3.0K | $24K | $135K | $23K | $80K | -- | $0 |
| Change in Receivables | -- | $476 | -$82 | $4.5K | -$1.4K | $50K | $4.9K | $528K | $217K | $518K |
| Change in Payables | -$390K | -$569K | -$418K | $807K | $331K | -$170K | -$2.19M | $42K | $1.80M | $33K |
| **Operating Cash Flow** | -$3.33M | -$3.28M | -$2.57M | -$3.04M | -$1.01M | -$4.09M | -$6.19M | -$5.20M | -$10.35M | -$21.94M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -- | -$30K | -- |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -- | -$10.38M | -- |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -- | -$30K | -- |
| **Financing Cash Flow** | $3.09M | $2.75M | $2.19M | $1.37M | $4.02M | $3.60M | $6.75M | $5.15M | $9.32M | $8.92M |
| **Net Change in Cash** | -$238K | -$537K | -$405K | -$1.68M | $3.01M | -$493K | $540K | -$55K | -$1.06M | -$13.01M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.27M | -$989K | -$1.30M | -$1.17M | -$1.32M | -$1.85M | -$1.16M | -$2.40M |
| Depreciation & Amortization | $465 | $466 | $466 | $465 | $466 | $465 | $467 | $466 |
| Stock-Based Compensation | $309K | $306K | $306K | $288K | $313K | $322K | $315K | $331K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $11 |
| Change in Payables | -$328K | $117K | $99K | -$462K | -$133K | $567K | -$363K | -$274K |
| **Operating Cash Flow** | -$860K | -$358K | -$358K | -$870K | -$840K | -$523K | -$1.09M | -$912K |
| Common Stock Issued | $0 | $0 | $75K | -- | $0 | $0 | $700K | -- |
| **Financing Cash Flow** | -$117K | $1.29M | $330K | $1.05M | $496K | $470K | $1.07M | $788K |
| **Net Change in Cash** | -$976K | $933K | -$27K | $179K | -$344K | -$53K | -$20K | -$124K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1575.3% | -734.4% | -520.2% | -346.6% | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -1615.8% | -766.9% | -556.2% | -359.4% | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -704.1% |
| Return on Assets (ROA) | -778.6% | -470.3% | -214.1% | -174.5% | -157.7% | -1133.3% | -468.7% | -410.1% | -393.4% | -435.3% |
| Current Ratio | 0.08x | 0.14x | 0.15x | 0.23x | 0.45x | 0.01x | 0.33x | 0.25x | 0.27x | 0.85x |
| Quick Ratio | 0.04x | 0.04x | 0.01x | 0.00x | 0.09x | 0.00x | 0.21x | 0.16x | 0.03x | 0.54x |
| **Revenue Growth (YoY)** | -45.5% | +10.7% | -43.6% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -1575.3% | -1857.3% | -1344.9% | -788.1% | -734.4% |
| **Net Profit Margin** | -- | -- | -- | -1615.8% | -1892.8% | -1376.9% | -816.3% | -766.9% |
| Return on Assets (ROA) | -1007.2% | -322.3% | -966.3% | -778.6% | -1579.7% | -877.1% | -805.8% | -470.3% |
| Current Ratio | 0.05x | 0.18x | 0.06x | 0.08x | 0.04x | 0.09x | 0.11x | 0.14x |
| Quick Ratio | 0.03x | 0.15x | 0.03x | 0.04x | 0.01x | 0.06x | 0.07x | 0.04x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -100.0% | -77.5% | +17.0% | -88.2% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
